New Measures to Report Medicine Disappearances
![Serialization/Aggregation - Live Online Training](files/eca/userImages/training.img/Z-ECA-Serialization-Live-Online-Training.jpg)
Recommendation
23/24 October 2024
Requirements, Challenges & Solutions
According to a press release from EDQM, Strasbourg, dated 04 July 2024, the Recommendation CM/Rec(2024)3 of the Committee of Ministers to member States on reporting of disappearances of medicinal products for human and veterinary use from the legal supply chain was adopted by the Council of Europe Committee of Ministers on 10 April 2024.
"The recommendation calls for member states to create and deploy suitable frameworks and systems for reporting, information sharing, and data collection, preferably under the guidance of the national competent authority for medicines. The recommendation further emphasizes the need for cooperation: addressing and preventing disappearances of medicines cannot be successful if not addressed in cooperation with law enforcement authorities and other stakeholders."
Background
In the past decade, Europe has witnessed numerous cases where medicines have disappeared from the legal supply chain, been tampered with, and reintroduced, posing significant risks to public health. These incidents often go unreported to health regulatory authorities because theft is considered a criminal matter and reported only to law enforcement. Fragmented reporting and lack of centralized data collection have led to an underestimation of the problem's scale.
For more details, please see the EDQM press release and Recommendation CM/Rec(2024)3.
Related GMP News
16.07.2024Templates for Shortage Prevention and Mitigation Plans issued by EMA
16.07.2024GDP Non-Compliance Report for Czech Wholesale Distributor
16.07.2024Checklist for Implementation of GDP Principles - Part 9: Transportation
12.06.2024EU adopts Supply Chain Law - Implications for pharmaceutical Companies
11.06.2024Checklist for Implementation of GDP Principles - Part 8: Self-Inspections